This report considers how the experience of the European regulatory system might be
applied to help strengthen the regulatory systems for medicines in the Region of the …

Health technology regulation and quality assurance are critical to the development of
national pharmaceutical policies, and implementing these actions is the responsibility of …

Regulatory transparency is an imperative characteristic of a reliable National Regulatory
Authority. In the region of the Americas, the process of building an open government is still …

Health regulation is regarded as one of public health's basic functions. Effective regulation of
medicines promotes and protects the public's health by guaranteeing medicines quality …

In the Region of the Americas, access to medicines and other health technologies
constitutes a priority for countries as they continue to move towards universal access to …

European Commission. Regulation (EC) No 726/2004 of the European Parliament and of
the Council of 31 March 2004 laying down Community procedures for the authorisation and …

Initiatives to tackle intemational health problems have evolved in the 20th century from
simple sets of measures and actors devoted to controlling the regional spread of some …

This chapter examines the Europeanization of medicines regulation across EU Member
States, which is motivated by the goal of a single European market for pharmaceuticals. The …

Given the international dimensions of the social, economic, and environmental determinants
of health and their manifestations, countries are increasingly negotiating with each other and …

Health care systems spend a relatively high percentage of their resources on the purchase
of medicines, and the poor spend a disproportionate amount of their income on …